Camlin Fine Sciences Ltd

Stage 4 · Declining · week 13

As of 20 Nov 2026, Camlin Fine Sciences is in Stage 4, the downtrend phase, now in week 13 (since 19 Aug 2026). It closed at ₹70.39, 60.3% below its 52-week high and below its 200-day average, which is falling. In Materials, 20.6% of stocks are in Stage 2.

Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. More about the company

₹70.4
Close, 20 Nov 2026
-1.01% on the day
₹1,352 Cr · Small cap
Market DowntrendMaterials 20.6% in Stage 2-17.9 pts / 20dSpecialty Chemicals 35.5%-23.7 pts

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

RS rank

Edge

—

CAMLINFINE is in a decline, 40% below its 200-day average. Declining stocks have lagged the market more than any other group; we wait for a base before looking again.

Its relative strength is 3 of 99, below the middle among NSE stocks over the past year. Specialty Chemicals ranks 16 of 106 industries by the strength of its stocks, among the leaders.

Is CAMLINFINE early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
Stage Cycle Timeline2023-08-24 → 2026-11-20
S4 32w
S1 14w
S2 38w
S4 32w
2023-08-242026-11-20
S1S2S3S4Setup score (0–10, dashed line at 5)
S3 4w → S2 6w → S3 2w → S4 32w → S1 14w → S4 6w → S1 2w → S2 38w → S3 10w → S4 32w → S1 9w → S4 13w current
Total tracked: 169 weeks across 12 stage runs.

CAMLINFINE among Specialty Chemicals82nd of 93 by relative strength

All 93 →
Stocks in Specialty Chemicals ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AETHERStage 3 · wk 297+10.8%
2NEOGENStage 2 · wk 2997+23.7%
3KANORICHEMStage 2 · wk 2596−1.0%
4YASHOStage 3 · wk 396+3.2%
5FCLStage 2 · wk 2594−15.0%
6NAVINFLUORStage 2 · wk 5293+25.7%
7BHAGERIAStage 2 · wk 2193−0.5%
8CHEMBONDCHStage 3 · wk 592+1.7%
…82CAMLINFINEStage 4 · wk 133−18.7%
vs 52W High
-60.3%
₹70.4 lo₹177.4 hi
60.3% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 13
1w13w26w
Week 13, established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-40.0%
200 DMA: ₹117.3 · sloping down
The stock is below its 200-day average, the mark of a downtrend. Stage analysis waits for the price to reclaim that line.
Rel Volume
0.68x
vs 50-day avg
Volume was well below average. Quiet sessions are common in a Stage 4 decline, and a low-volume bounce is easy to mistake for a reversal.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-18.7%
3M
-33.7%
6M
-41.9%
YTD
-52.6%
1Y
-58.8%
Sector
Materials
↓ Peaking
Stage 2%
20.6%
20d Δ
-17.9pp
1M return
+3.7%
3M return
-4.6%
Sector Stage-2 % · last 20 days
Sector has 94 Stage 2 leaders. See Materials Stage 2 →
Industry
Specialty Chemicals
↓ Peaking
Stage 2%
35.5%
20d Δ
-23.7pp
1M return
+4.8%
3M return
+0.0%
Industry Stage-2 % · last 20 days
Industry has 32 Stage 2 leaders. See Specialty Chemicals Stage 2 →

Mutual fund holdings

Held by 6 mutual funds in portfolios to October 2026: 3 active funds and 3 index funds and ETFs.

In October, no active fund changed its holding.

All 6 funds and what each did in October

Mutual funds holding CAMLINFINE: the ten largest and the month’s moves →

Fund details on DiscoverMF

Scan Membership
Not in any scan now.
Last appeared 27 Nov 2024
Recent Stage Timeline
2026-11-20S4
Wk 13 · Vol 0.68x
2026-11-19S4
Wk 13 · Vol 0.68x
2026-11-18S4
Wk 13 · Vol 0.63x
2026-11-17S4
Wk 13 · Vol 0.40x
2026-11-16S4
Wk 12 · Vol 0.61x
2026-11-13S4
Wk 12 · Vol 0.56x
2026-11-12S4
Wk 12 · Vol 0.77x
2026-11-11S4
Wk 12 · Vol 0.60x
2026-11-09S4
Wk 12 · Vol 0.93x
2026-11-06S4
Wk 11 · Vol 0.55x
2026-11-05S4
Wk 11 · Vol 2.76x
2026-11-04S4
Wk 11 · Vol 10.41x
Moving averages & range
50 DMA
₹88.5
200 DMA
₹117.3
52W High
₹177.4
52W Low
₹70.4
5D Low
₹70.4
Resistance levels (recent highs)
20d High
₹91.4
60d High
₹106.6
120d High
₹141.2
250d High
₹177.4
Next resistance
+29.8%
to 20d High
ROE
-9.6%
Profit margin -0.4%
Dividend Yield
0.00%
P/B 1.5

Camlin Fine Sciences: quick answers

What stage is Camlin Fine Sciences in?

As of 20 Nov 2026, Camlin Fine Sciences (CAMLINFINE) is in Stage 4, the downtrend phase. It entered Stage 4 on 19 Aug 2026 and is in week 13. What the four stages mean

Is Camlin Fine Sciences in an uptrend?

No. Camlin Fine Sciences is in a Stage 4 downtrend. It trades 40.0% below its 200-day average, which is falling.

How far is Camlin Fine Sciences from its 52-week high?

Camlin Fine Sciences closed at ₹70.39 on 20 Nov 2026, 60.3% below its 52-week high of ₹177. Its 52-week low is ₹70.39.

How has Camlin Fine Sciences performed over the past year?

As of 20 Nov 2026, Camlin Fine Sciences is down 58.8% over the past year and down 52.6% so far in 2026.

Which sector and industry is Camlin Fine Sciences in?

Camlin Fine Sciences is in the Specialty Chemicals industry, part of the Materials sector. 96 stocks in Materials are in Stage 2, 20.6% of the sector. See the Stage 2 stocks in Specialty Chemicals

About this companyMaterials· Specialty Chemicals

Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), tert butylcatechol (TBC), Guaiacol, and Veratrole; and health and wellness products comprising algae based products, such as Omega 3 fatty acids. It sells its prodycrts under the Xtendra, Nasure, Ezential, adorr, Dinamic, and Biosus brands. The company's products are used in food and beverage, pet food and rendering, animal nutrition, petrochemical, nutrition and health, biofuel, agrochemical, pharmaceutical, polymers, fragrance and flavor, and dyes and pigments industries. The company was formerly known as Camlin Fine Chemicals Ltd. and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.